161 related articles for article (PubMed ID: 36847987)
1. R0 Resection in Recurrent Gynecologic Malignancy: Pelvic Exenteration and Beyond.
Xu C; Garda AE; Kumar A
Curr Treat Options Oncol; 2023 Apr; 24(4):262-273. PubMed ID: 36847987
[TBL] [Abstract][Full Text] [Related]
2. Trends and current aspects of reconstructive surgery for gynecological cancers.
Loverro M; Aloisi A; Tortorella L; Aletti GD; Kumar A
Int J Gynecol Cancer; 2024 Mar; 34(3):426-435. PubMed ID: 38438169
[TBL] [Abstract][Full Text] [Related]
3. Does intra-operative radiation at the time of pelvic exenteration improve survival for patients with recurrent, previously irradiated cervical, vaginal, or vulvar cancer?
Backes FJ; Billingsley CC; Martin DD; Tierney BJ; Eisenhauer EL; Cohn DE; O'Malley DM; Salani R; Copeland LJ; Fowler JM
Gynecol Oncol; 2014 Oct; 135(1):95-9. PubMed ID: 25084510
[TBL] [Abstract][Full Text] [Related]
4. Pelvic exenteration for advanced pelvic malignancy.
Crowe PJ; Temple WJ; Lopez MJ; Ketcham AS
Semin Surg Oncol; 1999; 17(3):152-60. PubMed ID: 10504662
[TBL] [Abstract][Full Text] [Related]
5. Pelvic exenteration: long-term oncological results in a series of 106 patients.
De Wever I
Acta Chir Belg; 2011; 111(5):282-7. PubMed ID: 22191128
[TBL] [Abstract][Full Text] [Related]
6. Laparoscopic pelvic exenteration and laterally extended endopelvic resection for postradiation recurrent cervical carcinoma: Technical feasibility and short-term oncologic outcome.
Kanao H; Aoki Y; Omi M; Nomura H; Tanigawa T; Okamoto S; Chang EJ; Kurita T; Netsu S; Matoda M; Omatsu K; Matsuo K
Gynecol Oncol; 2021 Apr; 161(1):34-38. PubMed ID: 33423805
[TBL] [Abstract][Full Text] [Related]
7. Pelvic exenteration for gynaecological tumours: achievements and unanswered questions.
Höckel M; Dornhöfer N
Lancet Oncol; 2006 Oct; 7(10):837-47. PubMed ID: 17012046
[TBL] [Abstract][Full Text] [Related]
8. Pelvic exenteration for gynecologic malignancies: Postoperative complications and oncologic outcomes.
Romeo A; Gonzalez MI; Jaunarena J; Zubieta ME; Favre G; Tejerizo JC
Actas Urol Esp (Engl Ed); 2018 Mar; 42(2):121-125. PubMed ID: 28911880
[TBL] [Abstract][Full Text] [Related]
9. Pelvic Exenteration as Potential Cure and Symptom Relief in Advanced and Recurrent Gynaecological Cancer.
Soeda S; Furukawa S; Sato T; Ueda M; Kamo N; Endo Y; Kojima M; Nomura S; Kataoka M; Fujita S; Endo H; Takahashi T; Watanabe T; Yamada H; Fujimori K
Anticancer Res; 2019 Oct; 39(10):5631-5637. PubMed ID: 31570460
[TBL] [Abstract][Full Text] [Related]
10. Laterally extended endopelvic resection (LEER)--principles and practice.
Höckel M
Gynecol Oncol; 2008 Nov; 111(2 Suppl):S13-7. PubMed ID: 18723213
[TBL] [Abstract][Full Text] [Related]
11. Pelvic exenteration for recurrent gynecologic malignancy: a study of 28 consecutive patients at a single institution.
Jäger L; Nilsson PJ; Rådestad AF
Int J Gynecol Cancer; 2013 May; 23(4):755-62. PubMed ID: 23407096
[TBL] [Abstract][Full Text] [Related]
12. Laparoscopic laterally extended endopelvic resection procedure for gynecological malignancies.
Sozzi G; Petrillo M; Gallotta V; Di Donna MC; Ferreri M; Scambia G; Chiantera V
Int J Gynecol Cancer; 2020 Jun; 30(6):853-859. PubMed ID: 32332122
[TBL] [Abstract][Full Text] [Related]
13. Pelvic exenteration for recurrent or persistent gynecologic malignancies: Clinical and histopathologic factors predicting recurrence and survival in a modern cohort.
Straubhar AM; Chi AJ; Zhou QC; Iasonos A; Filippova OT; Leitao MM; Awowole IO; Abu-Rustum NR; Broach VA; Jewell EL; Sandhu JS; Sonoda Y
Gynecol Oncol; 2021 Nov; 163(2):294-298. PubMed ID: 34518053
[TBL] [Abstract][Full Text] [Related]
14. Pelvic exenteration for recurrent gynecologic malignancy: survival and morbidity analysis of the 45-year experience at UCLA.
Berek JS; Howe C; Lagasse LD; Hacker NF
Gynecol Oncol; 2005 Oct; 99(1):153-9. PubMed ID: 16054678
[TBL] [Abstract][Full Text] [Related]
15. Minimally Invasive Pelvic Exenteration for Gynecologic Malignancies: A Multi-Institutional Case Series and Review of the Literature.
Bizzarri N; Chiantera V; Ercoli A; Fagotti A; Tortorella L; Conte C; Cappuccio S; Di Donna MC; Gallotta V; Scambia G; Vizzielli G
J Minim Invasive Gynecol; 2019; 26(7):1316-1326. PubMed ID: 30611973
[TBL] [Abstract][Full Text] [Related]
16. Pelvic exenteration for recurrent or persistent gynecologic malignancies: a 10-year review of the Memorial Sloan-Kettering Cancer Center experience (1972-1981).
Lawhead RA; Clark DG; Smith DH; Pierce VK; Lewis JL
Gynecol Oncol; 1989 Jun; 33(3):279-82. PubMed ID: 2722049
[TBL] [Abstract][Full Text] [Related]
17. Extended pelvic resection for gynecological malignancies: A review of out-of-the-box surgery.
Daix M; Martinez Gomez C; Angeles MA; Tock S; Gladieff L; Gabiache E; Mery E; Martinez A; Cibula D; Ferron G
Gynecol Oncol; 2022 May; 165(2):393-400. PubMed ID: 35331571
[TBL] [Abstract][Full Text] [Related]
18. Pelvic Exenteration in Advanced Gynecologic Malignancies - Who Will Benefit?
Egger EK; Liesenfeld H; Stope MB; Recker F; Döser A; Könsgen D; Marinova M; Hilbert T; Exner D; Ellinger J; Mustea A
Anticancer Res; 2021 Jun; 41(6):3037-3043. PubMed ID: 34083295
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of gynecologic oncology patients in King Chulalongkorn Memorial Hospital - complications and outcome of pelvic exenteration.
Oranratanaphan S; Termrungruanglert W; Sirisabya N
Asian Pac J Cancer Prev; 2013; 14(4):2529-32. PubMed ID: 23725169
[TBL] [Abstract][Full Text] [Related]
20. The role of pelvic exenteration and reconstruction for treatment of advanced or recurrent gynecologic malignancies: Analysis of risk factors predicting recurrence and survival.
Park JY; Choi HJ; Jeong SY; Chung J; Park JK; Park SY
J Surg Oncol; 2007 Dec; 96(7):560-8. PubMed ID: 17708548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
